Medtronic to acquire wearable insulin patch maker EOFlow

Status
Not open for further replies.

Amity Island

Well-Known Member
Relationship to Diabetes
Type 1
The addition of EOFlow, together with Medtronic's Meal Detection Technology™ algorithm and next-generation continuous glucose monitor (CGM), is expected to expand the company's ability to address the needs of more individuals with diabetes, no matter where they are in their treatment journey or preference for how they want their insulin delivered.

 
Status
Not open for further replies.
Back
Top